| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1647
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-006
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-277
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-167 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-277
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-36 |
| filingDate |
2002-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d24a34f7cb2822122fc9558f244eeda
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe6eb9aef963494f6004afe5ec81a63c |
| publicationDate |
2004-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2004067257-A1 |
| titleOfInvention |
Pharmaceutical formulation |
| abstract |
The present invention relates to a pharmaceutical formulation comprising bicalutamide and an enteric polymer having a pK a from 3 to 6. The invention also relates to a daily pharmaceutical dose of bicalutamide provided by such a formulation. In addition, the invention relates to the use of such an enteric polymer in solid dispersion with bicalutamide for increasing the bioavailability of the bicalutamide; for reducing inter-patient variability in plasma concentrations of bicalutamide; or for treating and/or reducing the risk of prostate cancer in a patient. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007292509-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11173291-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006058381-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9663517-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9095513-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010310659-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009136577-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11344526-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1889610-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1889610-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008045600-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8293274-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8865735-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9447089-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009148518-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008138437-A1 |
| priorityDate |
2001-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |